‘Untimely’ to Alternate Authorized COVID-19 Vaccines Dosing, Schedules, FDA Says
(Reuters) – The U.S. Food and Drug Administration stated on Monday that the root of changing the licensed dosing or schedules of COVID-19 vaccines used to be untimely and no longer supported by the accessible files. The FDA stated it…